Abstract: Background: Determine predictors of early diagnosis and prevalence of OHS among patient with sleep disordered breathing (SDB) at Mansoura SDB unit.
increases health care resource use and the likelihood of requiring hospitalization compared with patients who have similar degrees of obesity [2] .
The prevalence of OHS in the general population is unknown, however; some reported prevalence of around 10-20% in outpatients presenting to sleep clinics. and a current estimate suggests around 0.37% of the US population may have OHS [1] . In the view of rapidly increasing numbers of individuals joining the ranks of the morbidly obese, and the significantly greater need they have for medical care, OHS needs to be considered as a significant clinical and social problem. Unfortunately it is also one that is frequently underestimated; despite the significant comorbidities and higher hospitalization rates were experienced [3] .
An early idintfication is a key element in managing patients with OHS. Current data however suggest that this disorder is frequently overlooked despite the high rate of hospitalization and medical care interaction received by these individuals in the years prior to a diagnosis being made [2] . Those with chronic stable disease frequently present through sleep clinics, where screening for hypoventilation may not be undertaken. Sleep histories in these patients are usually indistinguishable from simple OSA, with reports of excessive daytime sleepiness, loud snoring and nocturnal choking episodes common. [4] . clinically, it is important to distinguish between those individuals with simple OSA and those with OHS.
Although therapy directed towards correcting obstructed breathing at night will be effective in some patients with OHS, but in others persisting or worsening hypoventilation will occur [3] .
Several alveolar laboratory findings are supportive of OHS, yet the definitive test for hypoventilation is an arterial blood gas performed on room air. Elevated serum bicarbonate level due to metabolic compensation of respiratory acidosis is common in patients with OHS and points toward the chronic nature of hypercapnia [3] . Therefore, serum bicarbonate from venous blood could be used as a sensitive test to screen for chronic hypercapnia [4] .Additionally, hypoxemia during wakefulness is not common in patients with simple OSA.
Therefore, abnormal arterial oxygen saturation detected via finger pulse oximetry (SpO 2 ) during wakefulness should also lead clinicians to exclude OHS in patients with OSA [5] .
Aim of work
Determine predictors of early diagnosis and prevalence of OHS among patient with sleep disordered breathing (SDB) diagnosed at Mansoura SDB unit. 
Patients and Methods:

Statistical analysis:
The statistical analysis data was done by using excel and SPSS programs, statistical package for social science version 17. Qualitative data were presented as number and percent, chi square and student t-test were used to compare between two groups. The analysis of data was done to Test statistically significant difference between groups. P < 0.05 was considered statistically significant.
Results:
It was found that; among the 212 patients studied, the mean age was 46.6 ± 11.2, 112 patients (52.8%) were men and 100 (47.2%) were women. The mean value of BMI was 41.74 ± 10.60 kg/m 2 .Also it was found that; 128 (60.4%) patients were nonsmokers, 28 (13.2%) patients were Ex-smokers and 56(26.4%) patients were current smokers. 
Figure (2): Flow diagram (B) of studied cases
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Discussion:
In this study It was found that; the prevalence of SDB (AHI ≥5) in studied cases was 83.02% (176 out of 212), the majority of them had OSA (81.8% (144 out of 176) and 15 [9] , who reported a prevalence of 88% of SDB among 288 obese out patients referred to sleep clinic Goring and Collop [8] , also found that SDB was detected in 60% of patients with normal weight, which was comparable to our result of 66.7% of patients with normal weight had SDB, but it was difficult to draw statistically significant difference between obese and non-obese because of the small numbers of subjects in non-obese category.
In our study, it was found that; the prevalence of OHS among patients with SDB diagnosed at Mansoura SDB unit was 15.91% (28 out of 176), 16 .67% (28 out of 168) among obese patients with SDB, this is within the range reported in previous studies about the prevalence of OHS among patients with OSA that ranged from 9%-20%. In a large French retrospective study (n=1141), the prevalence of OHS was 11% among OSA patients and in a subgroup analysis of subjects with a BMI >40 kg/m 2 the prevalence of OHS was 24% [11] .
Studies that reported a high prevalence of OHS recruited patients with high BMI (≥40 kg/m 2 ), as in Mokhlesi et al [12] Our study showed that; 7.1% (2 out of 28) of our patients had hypoventilation without obstructive events (pure OHS), while 92.9% had concomitant OSA. These are supported by the previous studies that showed the majority of patients with OHS have concomitant OSA (90%). The residual 10% of patients have non-obstructive sleep hypoventilation (characterized by an AHI <5/hour) [1] , BaHammam [7] also found that prevalence of pure OHS was 6.25% and this result approach our result.
Previous studies that made an effort to determine risk issues or predictors of OHS in cohorts of patients with OSA reported mixed results [6] . The majority of patients have the typical symptoms of OSA, as loud snoring, episodes of choking during sleep with witnessed apneas, excessive daytime sleepiness, and early awakening headache [13] . In our study it was found that OHS patients having significantly higher symptoms of (witnessed apnea, early awakening headache and choking during sleep) than obese OSA patients (p < 0.05).
While obese OSA patients show significantly higher snoring than OHS patients. This higher snoring in OSA Vs OHS patients can be explained by the presence of some cases of OHS without OSA (pure OHS), while the significantly higher other symptoms of OSA (witnessed apnea, and choking during sleep) can be explained by significantly higher AHI in OHS Vs OSA patients, while higher early awakening headache in OHS Vs OSA patients can be explained by the more sleep hypoventilation in OHS Vs OSA patients as early awakening headache is caused by nocturnal CO 2 accumulation that lead to vasodilatation of cerebral vessels that is relieved by awakening with increase of ventilation by return of wakefulness drive.
We also found that OHS patients had significantly higher Berlin and STOP Bang score Versus obese OSA patients (2.93 ±0.27 Vs 2.69 ± 0.60, P =0.025) and (6.14 ± 0.86 Vs 5.00 ± 1.22, P = 0.001) respectively. These can be explained by higher severity of OSA in OHS patients Versus those with pure OSA patients.
In our study it was found that there is no significant differences in OSA Versus OHS patients as regard hemoglobin percentage and this can be explained by the small number of OHS patients and presence of four patients in OHS group that had co-morbid renal impairment which affects erythropoiesis and leads to anemia. Also other causes of decrease of hemoglobin can occur like parasitic infestations which were not searched for.
Kaw et al [14] , discovered that severity of obesity, severity of OSA and pulmonary restrictive impairment were risk factors for hypercapnia , this support our results of significantly higher BMI and AHI of OHS patients in comparison to obese OSA patients (51. [7] . The increase in BMI can explain the higher degree of restrictive ventilatory defect in OHS Vs OSA [16] . The higher AHI in OHS Vs OSA can support the hypothesis of daytime hypercapnia can be caused by higher severity of AHI that lead to severe hypoxemia with hypoventilation with subsequent rise of cerebrospinal fluid HCO 3 that lead to suppression of respiratory center with subsequent hypoventilation. The returns of HCO 3 to normal value take few hours after awakening [17] .
In current study it was found that the erect awake SpO 2 and PaO 2 was significantly lower in OHS than obese OSA patient (p<0.001) and a level ≤ 93% of erect awake SpO 2 can be used as a predictor for diagnosis of OHS with sensitivity of 97.1%, Specificity of 100%, PPV of 100%, NPV of 87.5% , and p <0.001. Basoglu and Tasbakan, [18] in their study established that daytime SpO 2 ≤ 95% had a sensitivity of 64.4% and specificity of 73.9%, (P=0.003) for recognizing OHS. So our result had more sensitivity and specificity at lower cutoff point. This was supported by Balachandran et al, who reported that Patients with OHS are unlikely to have a PaO 2 >70 mmHg so a SpO2< 93% should suggest the need for additional testing [19) .
In our study it was found that OHS patients had significantly higher serum HCO 3 values than obese OSA patients (28.74 ± 3.60Vs 24.71 ± 2.03, P = 0.001) and serum HCO 3 was identified as a predictor of OHS with a cutoff point of ≥ 28 mmol/L with sensitivity of 95.6%, specificity of 85.7% , PPV of 80%, NPV of 97%, and p <0.001. In previous studies
Mokhlesi et al [12] , in their sector of OSA patients found that a serum HCO 3 threshold of ≥ 27 mmol/L had a sensitivity of 92% and specificity of 50% in predicting OHS, Basoglu and (21) .,who found that a minimum Spo 2 of < 80% as the cutoff point
gives an acceptable discrimination for the diagnosis of OHS (sensitivity of 82.8%, specificity of 54.5%, PPV of 56.9%, NPV of 81.4%) .
Our study had some limitations. First, it was done at a single center in Egypt so multi center studies are needed in our country to confirm these results. Second, the number of all patients and patients with OHS was small; it would have been interesting to compare patients with OHS with OSA to pure OHS patients. Unfortunately we found only two patients with pure OHS, so statistical comparisons were not possible. Third, we cannot asses sleep hypoventilation in patients with OSA as there is no available non-invasive monitoring for PaCO 2 in our department like end tidal CO 2 or trans-cutaneous Co2 (PTcCO 2 ). If it is available, it can detect those OSA with sleep hypoventilation that later on after some times will develop OHS as it is well known that sleep hypoventilation precedes day time hypoventilation. So early detection of sleep hypoventilation with subsequent treatment can prevent the development of more cases of OHS with its higher comorbidities.
Conclusion
1. The overall prevalence of OHS in Mansoura SDB unit is 13.2% and the prevalence among patients with SDB is 15.91 % while 16.67% among obese patients with SDB.
2. The following cutoff points are a promising predictors that can be used in early diagnosis of OHS:
 Erect awake SpOR 2 R< 93% with sensitivity of 97.1% and Specificity of 100%.
 Serum HCOR 3 R>28 mmol/L with sensitivity of 85.7% and specificity of 95.6%.
 Basal (awake supine) SpOR 2 R %< 91.15% with sensitivity of 85.3% and specificity of 100%.
 AHI > 46.4 with sensitivity of 78.6% and specificity of 77.9%.
 The percentage of total sleep time of SpOR 2 R<90% >45.6% with sensitivity of 100% and specificity of 82.35%.
 Minimum SpOR 2 R% <75.5% with sensitivity of 70.6% and specificity of 85.7%.
Recommendations
 Multi-center studies are recommended to determine the prevalence of OHS among Egyptians.
 Screening for OHS among patient with SDB using the above cutoff points might be helpful in early diagnosis, prevention and better management of this serious disease.
